c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Alnylam Pharmaceuticals announces $1 billion stock repurchase program and executive departure
Investing.com | Nov 5, 2026 7:42 AM EST
Read original article